Healthcare Notification and Testing Toolkit
This toolkit provides a framework for use by state and local health departments for public notification as part of public health response to possible bloodborne pathogen exposures in a variety of healthcare settings.
Note: Bloodborne Pathogens Testing
In the event of a notification, recommendations for bloodborne pathogen screening are typically included. CDC staff are always available for consultation including discussion of testing algorithms for specific notification settings.
Please note that if potential exposures are less than six months earlier than the date of serologic screening, re-testing at a date greater than six months after last exposure may be warranted in order to identify recent infections that have not yet become serologically detectable. Alternatively, currently more costly viral nucleic acid testing may be considered as an initial screening tool to detect infections after recent high-risk exposures.
Suggested tests may vary according to the recency and likelihood of exposure and typically include:
- serologic testing for hepatitis C antibody, with reflex to HCV RNA testing if positive [PDF - 4 pages] (which may require an additional frozen serum specimen),
- serologic testing for hepatitis B surface antigen [PDF - 28 pages] (may also consider hepatitis B core antibody and surface antibody tests to determine past infection and immunity status) , and
- HIV testing
- Page last reviewed: May 31, 2015
- Page last updated: May 31, 2015
- Content source: